1. Introduction
1.1. Market Scope and Segmental Definition
1.2. Assumptions & Limitation
2. Research Methodology
2.1. Research Approach & Data Sources
2.2. Forecasting Model
3. Executive Summary
3.1. Analyst?s Insights
3.2. Top Line Market estimation
3.3. Value Chain Analysis
4. Market Forces
4.1. Key Industry Drivers, Restraints and Opportunities
4.2. Industry Trends
5. Market Outlook by Product (Current size & future market estimates)
5.1. Consumables
5.2. Instruments
5.3. Software and Services
6. Market Outlook by Test type (Current size & future market estimates)
6.1. Conventional Diagnostic Tests
6.1.1. Blood Tests
6.1.2. Urinalysis
6.2. Molecular Diagnostic Tests
7. Market Outlook by Infection Type (Current size & future market estimates)
7.1. Urinary Tract Infections
7.2. Pneumonia
7.3. Surgical Site Infections
7.4. Blood Stream Infections
7.5. Other Infections
8. Market Outlook by End-use (Current size & future market estimates)
8.1. Hospital
8.2. Clinics
8.3. Ambulatory Surgery Centers (ASC)
8.4. Others
9. Market Outlook by Regions (Current size & future market estimates)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.3. Asia Pacific
9.3.1. China
9.3.2. India
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.5. MEA
9.5.1. South Africa
9.5.2. Nigeria
10. Competitive Landscape
10.1. Market Share/Market Ranking Analysis
10.2. Competitive Market Scenario (New Product Innovations, Key Strategic Moves & Partnerships, Start-ups Ecosystem)
11. Company Profiles
ncludes: Company Overview, Product & Services Offerings, Financials (only for listed companies), New Developments and Innovation)
11.1. bioM�rieux SA
11.2. Abbott Laboratories
11.3. F. Hoffmann-La Roche Ltd.
11.4. Siemens Healthineers
11.5. Becton Dickinson and Company
11.6. Danaher Corporation
11.7. Thermo Fisher Scientific, Inc.
11.8. Seegene, Inc.
11.9. Qiagen